The Missing Part of America’s Pandemic Response
Many parts of the U.S. government, including its leading scientific agencies, are being blamed for the country’s chaotic and disorganized response to COVID-19. The CDC’s muddled and mistaken messaging about masks, testing, and the mechanism of viral spread sowed public confusion. The FDA’s extreme caution about approving boosters may have slowed the deployment of those vital measures. But a nation’s ability to weather a pandemic also depends upon its underlying ability to make major scientific discoveries, even—or especially—during moments of crisis. Success is not just a matter of luck; historically, the United States has made a series of strategic decisions that put researchers in a position to make timely breakthroughs. Yet amid the biggest health crisis in 100 years, the National Institutes of Health (NIH), the $42-billion-a-year engine of our nation’s biomedical-research infrastructure, has been strangely quiet.
In Washington, the NIH is a vanishingly rare entity: It enjoys bipartisan support. Since the end of World War II, its funding priorities have directed the research conducted at the nation’s medical schools, university science departments, and academic hospitals. It has furthered foundational research at the cellular and molecular levels, while also
You’re reading a preview, subscribe to read more.
Start your free 30 days